The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the CenturyInvestorPlace • 07/01/21
How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer DoudnaCNBC • 06/30/21
Implied Volatility Surging for Intellia Therapeutics (NTLA) Stock OptionsZacks Investment Research • 06/30/21
Intellia Therapeutics Stock Moves Higher After Capital Raise Of $600M Issued At $145/ShareBenzinga • 06/30/21
Cathie Wood's Ark ETFs are surging on big gains in CRISPR gene-editing stocks following the success of first human trialsBusiness Insider • 06/28/21
Intellia Therapeutics soars 58% after its gene-editing CRISPR therapy shows success in first human trialsBusiness Insider • 06/28/21